ArticleCureus2025
Severe Hyperthyroidism With Transient Hepatocellular Injury and Gallstone-Related Pancreatitis in Graves' Disease: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Graves' disease is an autoimmune thyroid disorder that can present with multisystem involvement, including transient hepatocellular dysfunction. While mild liver enzyme elevation is common in thyrotoxicosis, severe hepatic impairment and associated complications remain rare. We report the case of a 29-year-old man with newly diagnosed Graves' disease who initially presented with marked weight loss, palpitations, and biochemical thyrotoxicosis. He subsequently developed acute right upper quadrant pain, with imaging features suggestive of gallstone-related acute pancreatitis and deranged liver function tests. The hepatic impairment was attributed to possible gallstone migration in the context of rapid weight loss from hyperthyroidism, rather than thionamide-induced hepatotoxicity. This case highlights the complex interplay between hyperthyroidism and transient hepatocellular injury. It emphasizes the importance of considering thyroid dysfunction in the differential diagnosis of unexplained hepatic abnormalities, as well as the need for careful monitoring when initiating antithyroid therapy in patients with baseline liver dysfunction. Furthermore, it demonstrates that rapid metabolic shifts in untreated hyperthyroidism may predispose patients to gallstone formation and subsequent pancreatitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.